Stacey Jeffries Miles

Stacey Jeffries Miles

Auto-generated profile, based on publicly available information

Stacey Jeffries Miles

Division of Viral Diseases, U.S. Centers for Disease Control and Prevention

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HSHong Sun
Hong Sun
CHChelsea Harrington
Chelsea Harrington
NGNancy Gerloff
Nancy Gerloff
MMMark Mandelbaum
Mark Mandelbaum
SJStacey Jeffries-Miles
Stacey Jeffries-Miles
EVEverardo Vega
Everardo Vega
Surveillance and detection of polioviruses (PV) remain crucial to monitoring eradication progress. Intratypic differentiation (ITD) using the real-time RT-PCR kit is key to the surveillance workflow, where viruses are screened after cell culture isolation before a subset are verified by sequencing. The ITD kit is a series of real-time RT-PCR assays that screens cytopathic effect (CPE)-positive cell cultures using the standard WHO method for virus isolation. Because ITD screening is a critical procedure in the poliovirus identification workflow, validation of performance of real-time PCR platforms is a core requirement for the detection of poliovirus using the ITD kit. In addition, the continual update and improvement of the ITD assays to simplify interpretation in all platforms is necessary to ensure that all real-time machines are capable of detecting positive real-time signals. Four platforms (ABI7500 real-time systems, Bio-Rad CFX96, Stratagene MX3000P, and the Qiagen Rotor-Gene Q) were validated with the ITD kit and a redesigned poliovirus probe. The poliovirus probe in the real-time RT-PCR pan-poliovirus (PanPV) assay was re-designed with a double-quencher (Zen™) to reduce background fluorescence and potential false negatives. The updated PanPV probe was evaluated with a panel consisting of 184 polioviruses and non-polio enteroviruses. To further validate the updated PanPV probe, the new assay was pilot tested in five Global Polio Laboratory Network (GPLN) laboratories (Madagascar, India, Philippines, Pakistan, and Democratic Republic of Congo). The updated PanPV probe performance was shown to reduce background fluorescence and decrease the number of false positives compared to the standard PanPV probe.

3 July 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LSLeanna Sayyad
Leanna Sayyad
CHChelsea Harrington
Chelsea Harrington
CCChristina J. Castro
Christina J. Castro
HBHanen Belgasmi-Allen
Hanen Belgasmi-Allen
SMStacey Jeffries Miles
Stacey Jeffries Miles
NGNancy Gerloff
Nancy Gerloff
The Global Specialized Polio Laboratory at CDC supports the Global Poliovirus Laboratory Network with environmental surveillance (ES) to detect the presence of vaccine strain polioviruses, vaccine-derived polioviruses, and wild polioviruses in high-risk countries. Environmental sampling provides valuable supplementary information, particularly in areas with gaps in surveillance of acute flaccid paralysis (AFP) mainly in children less than 15 years. In collaboration with Guatemala’s National Health Laboratory (Laboratorio Nacional de Salud Guatemala), monthly sewage collections allowed screening enterovirus (EV) presence without incurring additional costs for sample collection, transport, or concentration. Murine recombinant fibroblast L-cells (L20B) and human rhabdomyosarcoma (RD) cells are used for the isolation of polioviruses following a standard detection algorithm. Though non-polio-Enteroviruses (NPEV) can be isolated, the algorithm is optimized for the detection of polioviruses. To explore if other EV’s are present in sewage not found through standard methods, five additional cell lines were piloted in a small-scale experiment, and next-generation sequencing (NGS) was used for the identification of any EV types. Human lung fibroblast cells (HLF) were selected based on their ability to isolate EV-A genus. Sewage concentrates collected between 2020–2021 were isolated in HLF cells and any cytopathic effect positive isolates used for NGS. A large variety of EVs, including echoviruses 1, 3, 6, 7, 11, 13, 18, 19, 25, 29; coxsackievirus A13, B2, and B5, EV-C99, EVB, and polioviruses (Sabin 1 and 3) were identified through genomic typing in NGS. When the EV genotypes were compared by phylogenetic analysis, it showed many EV’s were genomically like viruses previously isolated from ES collected in Haiti. Enterovirus occurrence did not follow a seasonality, but more diverse EV types were found in ES collection sites with lower populations. Using the additional cell line in the existing poliovirus ES algorithm may add value by providing data about EV circulation, without additional sample collection or processing. Next-generation sequencing closed gaps in knowledge providing molecular epidemiological information on multiple EV types and full genome sequences of EVs present in wastewater in Guatemala.

23 December 2025 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
HBHanen Belgasmi-Allen
Hanen Belgasmi-Allen
JHJamaica Hill
Jamaica Hill
SMStacey Jeffries Miles
Stacey Jeffries Miles
LSLeanna Sayyad
Leanna Sayyad
HEHala Elahi
Hala Elahi
NGNancy Gerloff
Nancy Gerloff
Environmental surveillance (ES) for poliovirus is a critical component of global eradication efforts, enabling the detection of virus circulation in communities, even in the absence of acute flaccid paralysis (AFP) cases. To monitor poliovirus circulation in a high-risk setting, ES was established in 2016 in Haïti in two cities (Port-au-Prince and Gonaïves) and expanded to five cities, adding Saint Marc, Cap Haïtien, and Port-de-Paix by 2023. Wastewater samples were collected monthly from 13 sites in urban areas and processed at CDC-Atlanta using the concentration and filtration elution (CaFÉ) method developed to concentrate enteroviruses, including polioviruses. Virus isolation was performed using poliovirus-sensitive (L20B) cells and enterovirus-sensitive (RD) cells, followed by molecular detection screening via real-time reverse transcription PCR designed for enterovirus and poliovirus typing. Between 2020 and 2023, sporadic Sabin-like poliovirus vaccine strains of serotypes 1 and 3 were detected, and no wild poliovirus (WPV) or vaccine-derived poliovirus (VDPV) was identified. The overall enterovirus detection rates ranged from 36% to 91% in 2020, 12% to 58% in 2021, 16% to 60% in 2022, and 27% to 73% in 2023, with some detection rates at some sites much lower than the optimal 50% target for global ES sites. Based on the lower detection rate, used as the main quality indicator for optimal ES, two sampling sites were discontinued in 2023 (one in Saint Marc and one in Cap Haïtien). The findings underscore the importance of high-performing ES in high-risk regions to augment AFP surveillance and serve as an early warning indicator of poliovirus circulation. IMPORTANCE: Poliovirus environmental surveillance (ES) is a critical tool for detecting virus circulation before symptomatic cases of acute flaccid paralysis occur, especially in areas with inadequate surveillance. Haïti, a high-risk country for poliovirus transmission, faced numerous challenges from 2020 to 2023 that impacted ES operations, including political instability, humanitarian crisis, and site closures. This study provides a comprehensive evaluation of ES performance during that period, offering insights into surveillance resilience and sustainability in low-resource settings. The findings are timely and relevant, particularly in the context of the recent circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in Europe and Africa, and contribute to optimizing ES strategies globally to support polio eradication efforts.

14 October 2026 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
NGNancy Gerloff
Nancy Gerloff
HSHong Sun
Hong Sun
BSBrandon Short
Brandon Short
EHEric Harvey
Eric Harvey
SJStacey Jeffries-Miles
Stacey Jeffries-Miles
MBMaël Bessaud
Maël Bessaud
This study details the development and validation of five real-time RT-PCR assays for the intratypic differentiation (ITD) of polioviruses and the discrimination of vaccine-derived polioviruses (VDPVs) utilizing locked nucleic acid (LNA) technology and primer overhangs. Updated assays, including wild-type 1/Qβ duplex (WPV1), VDPVs 1 and 3, wild-type 3, and novel oral poliovirus type 2 (nOPV2), were designed in response to challenges posed by genetic diversity and detection gaps in existing protocols following outbreaks, and the introduction of a new vaccine replacing the Sabin 2 oral poliovirus vaccine (OPV). The CDC’s Polio and Picornavirus Branch led assay development, supporting global surveillance efforts with kits tailored for use across multiple real-time PCR platforms. Comprehensive virus collections representing all three poliovirus serotypes, nonpolio enteroviruses, and vaccine seed strains were used in the validation. Assay performance was assessed through piloting in poliovirus reference laboratories across outbreak regions, including Central Asia and Africa. Combining primers with AT-rich overhangs enhanced fluorescence, improving interpretation of weak signals for VDPV1 and WPV1 assays, and boosting analytical sensitivity for the VDPV3 assay by 10-fold to 100-fold (100%). The new assays enabled reliable detection of extinct WPV3 (100% sensitivity and 96.97% specificity), the circulating genotype WPV1 (100% sensitivity and 98.72% specificity), and discrimination of Sabin 1 and 3 from vaccine-derived strains, and the discrimination of nOPV2 from Sabin 2 (100% specificity) from surveillance samples. These advancements mark a significant milestone in molecular diagnostics for poliovirus eradication, supporting surveillance and response efforts worldwide, with remaining pockets of circulating VDPVs and wild-type 1 viruses. IMPORTANCE: Recent poliovirus detections from wastewater in non-endemic regions sparked renewed interest in the agent. Limited access to extinct polioviruses for validation studies hinders diagnostic laboratories from designing and validating real-time RT-PCR assays for specific and sensitive detection in wastewater or stools. There are currently no commercial tests that can detect and type all poliovirus serotypes that have been assessed with recent endemic or seed viruses used by vaccine manufacturers, making the intratypic differentiation unique. This work describes the redesign and validation of the five RT-PCR assays with various poliovirus strains such as vaccine seed strains, outbreak strains, and eradicated viruses. Locked nucleic acids and primer overhangs were applied to the primer and probe design, resulting in advanced laboratory capability to detect contemporary poliovirus strains, strengthening surveillance in support of the global poliovirus eradication activities.